Multicenter cross-calibration of I-123 metaiodobenzylguanidine heart-to-mediastinum ratios to overcome camera-collimator variations

Journal of Nuclear Cardiology

Volumn 21, Issue 5, 2014, Pages 970-978

  Nakajima, Kenichi ^a   Okuda, Koichi ^b   Yoshimura, Mana ^c   Matsuo, Shinro ^a   Wakabayashi, Hiroshi ^a   Imanishi, Yasuhiro ^d   Kinuya, Seigo ^a  

^a KANAZAWA UNIVERSITY HOSPITAL   (Japan)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

^c TOKYO MEDICAL UNIVERSITY   (Japan)

^d SUZUKA GENERAL HOSPITAL   (Japan)

Author keywords

calibration phantom; collimator; heart to mediastinum ratio; Metaiodobenzylguanidine (MIBG) imaging; standardization

Indexed keywords

(3 IODOBENZYL)GUANIDINE; RADIOPHARMACEUTICAL AGENT;

ARTIFACT; CALIBRATION; CLINICAL TRIAL; DEVICE FAILURE ANALYSIS; DIAGNOSTIC USE; EQUIPMENT DESIGN; GAMMA CAMERA; HEALTH CARE QUALITY; HEART; HEART MUSCLE; HUMAN; IMAGE QUALITY; JAPAN; MEDIASTINUM; METABOLISM; MULTICENTER STUDY; PHYSIOLOGY; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; STANDARDS;

3-IODOBENZYLGUANIDINE; ARTIFACTS; CALIBRATION; EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; GAMMA CAMERAS; HEART; HUMANS; JAPAN; MEDIASTINUM; MYOCARDIUM; PHANTOMS, IMAGING; QUALITY ASSURANCE, HEALTH CARE; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84929941912     PISSN: 10713581     EISSN: 15326551     Source Type: Journal    
DOI: 10.1007/s12350-014-9916-2     Document Type: Article

References (20)

1. Verberne HJ, Brewster LM, Somsen GA, van Eck-Smit BL. Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: A systematic review. Eur Heart J 2008;29:1147-59.
2. 123I-MIBG imaging: A meta-analysis from the studies performed in Japan. Ann Nucl Med 2011;25:101-7.
3. Tamaki N. Guidelines for clinical use of cardiac nuclear medicine (JCS 2005). Circ J 2005;69:1125-202 (Revision on the web site 2010).
4. 123I-metaiodobenzylguanidine imaging allows early identification of dementia with Lewy bodies during life. Eur J Nucl Med Mol Imaging 2008;35:1636-41.
5. Nakajima K, Yoshita M, Matsuo S, Taki J, Kinuya S. Iodine-123-MIBG sympathetic imaging in Lewy-body diseases and related movement disorders. Q J Nucl Med Mol Imaging 2008;52:378-87.
6. Merlet P, Benvenuti C, Moyse D, Pouillart F, Dubois-Rande JL, Duval AM, et al. Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy. J Nucl Med 1999;40:917-23.
7. Veltman CE, Boogers MJ, Meinardi JE, Al Younis I, Dibbets-Schneider P, Van der Wall EE, et al. Reproducibility of planar (123)I-meta-iodobenzylguanidine (MIBG) myocardial scintigraphy in patients with heart failure. Eur J Nucl Med Mol Imaging 2012;39:1599-608.
8. 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology. Eur J Nucl Med Mol Imaging 2010;37:1802-12.
9. Nakajima K, Matsubara K, Ishikawa T, Motomura N, Maeda R, Akhter N, et al. Correction of iodine-123-labeled meta-iodobenzylguanidine uptake with multi-window methods for standardization of the heart-to-mediastinum ratio. J Nucl Cardiol 2007;14:843-51.
10. Nakajima K, Okuda K, Matsuo S, Yoshita M, Taki J, Yamada M, et al. Standardization of metaiodobenzylguanidine heart to mediastinum ratio using a calibration phantom: Effects of correction on normal databases and a multicentre study. Eur J Nucl Med Mol Imaging 2012;39:113-9.
11. Okuda K, Nakajima K, Hosoya T, Ishikawa T, Konishi T, Matsubara K, et al. Semi-automated algorithm for calculating heart-to-mediastinum ratio in cardiac Iodine-123 MIBG imaging. J Nucl Cardiol 2011;18:82-9.
12. Jacobson AF, Senior R, Cerqueira MD, Wong ND, Thomas GS, Lopez VA, et al. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol 2010;55:2212-21.
13. 123I-mIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure. JACC Cardiovasc Imaging 2013;6:772-84.
14. 123I-MIBG heart/mediastinum ratios: A phantom study. Eur J Nucl Med Mol Imaging 2005;32:1100-7.
15. Inoue Y, Suzuki A, Shirouzu I, Machida T, Yoshizawa Y, Akita F, et al. Effect of collimator choice on quantitative assessment of cardiac iodine 123 MIBG uptake. J Nucl Cardiol 2003;10:623-32.
16. Nakajima K. Normal values for nuclear cardiology: Japanese databases for myocardial perfusion, fatty acid and sympathetic imaging and left ventricular function. Ann Nucl Med 2010;24:125-35.
17. 123I cardiac SPECT imaging with deconvolution of septal penetration. Nucl Med Commun 2006;27:551-8.
18. 123I-metaiodobenzylguanidine cardiac sympathetic imaging. J Nucl Med 2013;54:707-13.
19. 123I-MIBG cardiac scintigraphy for the diagnosis of Lewy body-related disorders. Mov Disord 2011;26:1218-24.
20. Nakajima K, Nakata T, Yamada T, Yamashina S, Momose M, Kasama S, et al. A prediction model for 5-year cardiac mortality in patients with chronic heart failure using I-123 meta-iodobenzylguanidine imaging. Eur J Nucl Med Mol Imaging 2014. doi:10.1007/s00259-014-2759-x.